Page 26 - 10 Most Trusted Diagnostic Companies in India 2022
P. 26

FOCUS POINT


            Some of the recent developments/                       •  In  July  2021,  Generic  Health                                •  In  May  2021,  Cipla  launched                      of Oxygen Enrichment Unit (OEU).

            investments in the  Indian  phar-                      (an       Australia-based           subsid-                        a real-time  COVID-19  detec-                           The unit can deliver medical air in
            maceutical  sector  are as follows:                    iary  of  Lupin Limited)  signed  an                               tion  kit  ‘ViraGen’  that  is  based                   the range of ~15 litres per minute,


            •  In  November  2021,  US-based                       agreement with  Southern  Cross                                    on multiplex polymerase  chain                          with oxygen purity of >90%. It trans-
            Akston Biosciences  announced                          Pharma  Pty  Ltd.  (SCP).  Under                                   reaction         (PCR)        technology.               ferred the technology to MSMEs—

            that it will start the clinical trial of               this  deal,  Lupin  will  acquire  100%                                                                                    Conquerent Control Systems Pvt.
            its  second-generation COVID-19                        shares  of  SCP.  The  acquisition is                              •  In  May  2021,  the  Govern-                         Ltd., A B Elasto Products Pvt. Ltd.
            vaccine  ‘AKS-452’  in  India  soon.                   expected  to further  strengthen                                   ment       of     India    invited      R&D             and  Automation  Engineers,  Mech

                                                                   Lupin’s      foothold       in    Australia.                       proposals  on critical  compo-                          Air Industries and Auto Malleable.
            •   In    October         2021,       Astra-

            Zeneca  India  launched  a  Clinical                   •  In  July  2021,  Generic  Health                                nents  and  innovations  in  oxygen                     •  In  April  2021,  National  Pharma-
            Data  and  Insights  (CDI)  division                   (an       Australia-based           subsid-                        concentrators  by  June  15,  2021                      ceutical  Pricing Authority (NPPA)
            to  further  strengthen  its  global                   iary  of  Lupin Limited)  signed  an                               .                                                       fixed  the  price  of  81  medicines

            presence  and  manage  data-re-                                                                                           •  In May 2021, Indian Immunolog-                       including       off-patent        anti-dia-
            lated aspects of its  clinical  trials                 agreement with  Southern  Cross                                    icals Ltd. (IIL) and Bharat Immuno-                     betic drugs allowing due benefits
            .                                                      Pharma  Pty  Ltd.  (SCP).  Under                                   logicals  and  Biologicals  Corpora-                    of patent expiry to the  patients
            •   In    September           2021,      the           this  deal,  Lupin  will  acquire  100%                            tion (BIBCOL)  inked  technology

            Indian  government contributed                         shares  of  SCP.  The  acquisition is                              transfer pacts with Bharat Biotech                      •  In February 2021,  Aurobindo
            US$ 4 billion to the pharma-                           expected  to further  strengthen                                                                                           Pharma announced plans to procure
            ceutical  and  medical  industries.                    Lupin’s      foothold       in    Australia.                       to  develop  the  vaccine  locally  to                  solar power from two open access
                                                                                                                                      boost India’s vaccination drive. The
            •  In August 2021, Glenmark collab-                    •  In  June  2021,  Sun Pharmaceu-                                 two PSUs plan to start production

            orated with SaNOtize to introduce                                                                                         of  vaccines  by September  2021.
            spray for COVID-19  treatment                          ticals acquired the patent license
            in India and  other  Asian markets.                    for  Dapagliflozin from Astra-                                     •  In May 2021, Eli Lilly & Company
                                                                   Zeneca.  The  company will  be

            •  In August 2021, Uniza Group, an                     distributing  and  promoting  the                                  issued        non-exclusive           volun-
            Ahmedabad-based               pharmaceu-               drug under the brand name ‘Oxra’.                                  tary licenses  to  pharmaceutical
            tical  firm,  signed  an  agreement                                                                                       companies—Cipla             Ltd.,      Lupin

            with Lysulin Inc. (an US-based firm)                   •  In June  2021,  Lupin Ltd.                                      Ltd.,  Natco  Pharma & Sun  Phar-
            to  introduce  Lysulin,  a  nutritional                announced  its  intention to  enter                                maceutical         Industries       Ltd.—to
            product for Indian consumers.                          the digital  healthcare space in                                   produce and  distribute Barici-


            •  In  August 2021,  Alkem  Labo-                      India. It incorporated Lupin Digital                               tinib, a drug for treating COVID-19.

            ratories  introduced  Famotidine                       Health Ltd., a wholly owned subsid-
            and  Ibuprofen tablets to treat                        iary, to provide a digital therapeu-                               •   In    April     2021,     the     CSIR-

            osteoarthritis        and      rheumatoid              tics  platform for medical  practi-                                CMERI,  Durgapur, indigenously
            arthritis  symptoms  in the  US.                       tioners and patients in the country.                               developed           the        technology


          |26  thecorporatereview.com  | India  | Vol. 3  |  Issue  3 | March 2022                                                                                                                                                     |27
   21   22   23   24   25   26   27   28   29   30   31